300558 贝达药业
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)7.6466.8923.0918.80418.371
总资产报酬率 ROA (%)4.4994.0812.0516.66112.952
投入资产回报率 ROIC (%)5.2874.8282.4527.73714.307

边际利润分析
销售毛利率 (%)83.80783.53288.69492.23392.573
营业利润率 (%)18.69210.9953.98917.61536.394
息税前利润/营业总收入 (%)19.89114.72411.07217.41637.923
净利润/营业总收入 (%)17.28013.5835.25016.90032.139

收益指标分析
经营活动净收益/利润总额(%)84.85175.225-22.02889.13355.824
价值变动净收益/利润总额(%)9.333-4.244-23.5454.09443.900
营业外收支净额/利润总额(%)-1.49316.147-8.251-1.455-2.101

偿债能力分析
流动比率 (X)0.8590.8460.8231.8614.218
速动比率 (X)0.6960.6650.6461.5313.787
资产负债率 (%)38.81041.49437.32525.2840.208
带息债务/全部投入资本 (%)27.16029.68724.748-1.880-0.986
股东权益/带息债务 (%)258.578229.159292.509-4,701.270-8,857.803
股东权益/负债合计 (%)155.208138.352164.239287.637381.518
利息保障倍数 (X)13.4999.1361.499322.09416.649

营运能力分析
应收账款周转天数 (天)29.63652.74445.61317.75610.456
存货周转天数 (天)219.236311.364445.819497.287418.790